Estimation of frequency shift in cardiovascular variability signals

Ilkka Korhonen, J. Philip Saul, Väinö Turjanmaa

Research output: Contribution to journalArticleScientificpeer-review

4 Citations (Scopus)

Abstract

Spectral analysis of heart rate (HR) and blood pressure (BP) oscillations has traditionally been concen-trated on the spectral power. However, a shift in spectral frequency characterizes the variability better than the power in some cases. We compared three parameters to estimate spectral shift within the low frequency (LF, 0.04-0.15Hz) band in HR and BP variability: mean (fmean), median (fmed), and central fre-quency (fc). Parameter variance (pstd) and sensitivity to noise were estimated with realistic HR, systolic BP (SBP) and diastolic BP (DBP) data. The fmean showed the lowest parameter variance both for AR (e.g. for SBP pstd 3.1 vs. 4.8 vs. 4.7mHz for fmean, fmed and fc, respectively; p<0.001) and FFT based (e.g. for SBP pstd 4.7 vs 7.7mHz for fmean and fmed, respectively; p<0.001) methods. Furthermore, fmean was least sensitive to noise. The fc showed the poorest performance being especially sensitive to noise. We computed fmean for experimental data from 14 healthy males in control and pharmacological blockade conditions. When parasympathetic control was reduced, LF oscillations of HR and BP tend to shift to-wards lower frequencies. These shifts are often masked if the fmean is not computed separately for differ-ent spectral bands. Thus, band-wise analysis of spectral shift in cardiovascular variability signals pro-vides important information. To analyze the spectral shift, the fmean is the preferred parameter, which outweighs especially the fc; the parameter used in the most previous studies, which have quantified the frequency of oscillations in cardiovascular signals.
Original languageEnglish
Pages (from-to)465-470
Number of pages6
JournalMedical and Biological Engineering and Computing
Volume39
Issue number4
DOIs
Publication statusPublished - 2001
MoE publication typeA1 Journal article-refereed

Fingerprint

Blood pressure
Fast Fourier transforms
Spectrum analysis

Cite this

Korhonen, Ilkka ; Philip Saul, J. ; Turjanmaa, Väinö. / Estimation of frequency shift in cardiovascular variability signals. In: Medical and Biological Engineering and Computing. 2001 ; Vol. 39, No. 4. pp. 465-470.
@article{41f8bb4ed49c471b921f8352e5381483,
title = "Estimation of frequency shift in cardiovascular variability signals",
abstract = "Spectral analysis of heart rate (HR) and blood pressure (BP) oscillations has traditionally been concen-trated on the spectral power. However, a shift in spectral frequency characterizes the variability better than the power in some cases. We compared three parameters to estimate spectral shift within the low frequency (LF, 0.04-0.15Hz) band in HR and BP variability: mean (fmean), median (fmed), and central fre-quency (fc). Parameter variance (pstd) and sensitivity to noise were estimated with realistic HR, systolic BP (SBP) and diastolic BP (DBP) data. The fmean showed the lowest parameter variance both for AR (e.g. for SBP pstd 3.1 vs. 4.8 vs. 4.7mHz for fmean, fmed and fc, respectively; p<0.001) and FFT based (e.g. for SBP pstd 4.7 vs 7.7mHz for fmean and fmed, respectively; p<0.001) methods. Furthermore, fmean was least sensitive to noise. The fc showed the poorest performance being especially sensitive to noise. We computed fmean for experimental data from 14 healthy males in control and pharmacological blockade conditions. When parasympathetic control was reduced, LF oscillations of HR and BP tend to shift to-wards lower frequencies. These shifts are often masked if the fmean is not computed separately for differ-ent spectral bands. Thus, band-wise analysis of spectral shift in cardiovascular variability signals pro-vides important information. To analyze the spectral shift, the fmean is the preferred parameter, which outweighs especially the fc; the parameter used in the most previous studies, which have quantified the frequency of oscillations in cardiovascular signals.",
author = "Ilkka Korhonen and {Philip Saul}, J. and V{\"a}in{\"o} Turjanmaa",
note = "Project code: T0SU00171 (IBIS)",
year = "2001",
doi = "10.1007/BF02345369",
language = "English",
volume = "39",
pages = "465--470",
journal = "Medical and Biological Engineering and Computing",
issn = "0140-0118",
publisher = "Springer",
number = "4",

}

Estimation of frequency shift in cardiovascular variability signals. / Korhonen, Ilkka; Philip Saul, J.; Turjanmaa, Väinö.

In: Medical and Biological Engineering and Computing, Vol. 39, No. 4, 2001, p. 465-470.

Research output: Contribution to journalArticleScientificpeer-review

TY - JOUR

T1 - Estimation of frequency shift in cardiovascular variability signals

AU - Korhonen, Ilkka

AU - Philip Saul, J.

AU - Turjanmaa, Väinö

N1 - Project code: T0SU00171 (IBIS)

PY - 2001

Y1 - 2001

N2 - Spectral analysis of heart rate (HR) and blood pressure (BP) oscillations has traditionally been concen-trated on the spectral power. However, a shift in spectral frequency characterizes the variability better than the power in some cases. We compared three parameters to estimate spectral shift within the low frequency (LF, 0.04-0.15Hz) band in HR and BP variability: mean (fmean), median (fmed), and central fre-quency (fc). Parameter variance (pstd) and sensitivity to noise were estimated with realistic HR, systolic BP (SBP) and diastolic BP (DBP) data. The fmean showed the lowest parameter variance both for AR (e.g. for SBP pstd 3.1 vs. 4.8 vs. 4.7mHz for fmean, fmed and fc, respectively; p<0.001) and FFT based (e.g. for SBP pstd 4.7 vs 7.7mHz for fmean and fmed, respectively; p<0.001) methods. Furthermore, fmean was least sensitive to noise. The fc showed the poorest performance being especially sensitive to noise. We computed fmean for experimental data from 14 healthy males in control and pharmacological blockade conditions. When parasympathetic control was reduced, LF oscillations of HR and BP tend to shift to-wards lower frequencies. These shifts are often masked if the fmean is not computed separately for differ-ent spectral bands. Thus, band-wise analysis of spectral shift in cardiovascular variability signals pro-vides important information. To analyze the spectral shift, the fmean is the preferred parameter, which outweighs especially the fc; the parameter used in the most previous studies, which have quantified the frequency of oscillations in cardiovascular signals.

AB - Spectral analysis of heart rate (HR) and blood pressure (BP) oscillations has traditionally been concen-trated on the spectral power. However, a shift in spectral frequency characterizes the variability better than the power in some cases. We compared three parameters to estimate spectral shift within the low frequency (LF, 0.04-0.15Hz) band in HR and BP variability: mean (fmean), median (fmed), and central fre-quency (fc). Parameter variance (pstd) and sensitivity to noise were estimated with realistic HR, systolic BP (SBP) and diastolic BP (DBP) data. The fmean showed the lowest parameter variance both for AR (e.g. for SBP pstd 3.1 vs. 4.8 vs. 4.7mHz for fmean, fmed and fc, respectively; p<0.001) and FFT based (e.g. for SBP pstd 4.7 vs 7.7mHz for fmean and fmed, respectively; p<0.001) methods. Furthermore, fmean was least sensitive to noise. The fc showed the poorest performance being especially sensitive to noise. We computed fmean for experimental data from 14 healthy males in control and pharmacological blockade conditions. When parasympathetic control was reduced, LF oscillations of HR and BP tend to shift to-wards lower frequencies. These shifts are often masked if the fmean is not computed separately for differ-ent spectral bands. Thus, band-wise analysis of spectral shift in cardiovascular variability signals pro-vides important information. To analyze the spectral shift, the fmean is the preferred parameter, which outweighs especially the fc; the parameter used in the most previous studies, which have quantified the frequency of oscillations in cardiovascular signals.

U2 - 10.1007/BF02345369

DO - 10.1007/BF02345369

M3 - Article

VL - 39

SP - 465

EP - 470

JO - Medical and Biological Engineering and Computing

JF - Medical and Biological Engineering and Computing

SN - 0140-0118

IS - 4

ER -